Business Description
Spruce Biosciences Inc
NAICS : 541714
SIC : 2833
ISIN : US85209E1091
Share Class Description:
SPRB: Ordinary SharesDescription
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 20.9 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.1 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -2.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 36.8 | |||||
| 3-Year EPS without NRI Growth Rate | 36.9 | |||||
| 3-Year FCF Growth Rate | 42.8 | |||||
| 3-Year Book Growth Rate | -33.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.46 | |||||
| 9-Day RSI | 49.74 | |||||
| 14-Day RSI | 37.72 | |||||
| 6-1 Month Momentum % | -38.63 | |||||
| 12-1 Month Momentum % | -67.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.18 | |||||
| Quick Ratio | 4.18 | |||||
| Cash Ratio | 3.94 | |||||
| Days Sales Outstanding | 542.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -20.8 | |||||
| Shareholder Yield % | -154.81 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -515.34 | |||||
| Net Margin % | -474.96 | |||||
| FCF Margin % | -329.81 | |||||
| ROE % | -55.09 | |||||
| ROA % | -42.21 | |||||
| ROIC % | -447.89 | |||||
| ROC (Joel Greenblatt) % | -3665.28 | |||||
| ROCE % | -51.47 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.98 | |||||
| PB Ratio | 0.41 | |||||
| Price-to-Tangible-Book | 0.41 | |||||
| EV-to-EBIT | 0.93 | |||||
| EV-to-Forward-EBIT | -0.42 | |||||
| EV-to-EBITDA | 0.93 | |||||
| EV-to-Forward-EBITDA | -0.42 | |||||
| EV-to-Revenue | -4.37 | |||||
| EV-to-Forward-Revenue | 16.98 | |||||
| EV-to-FCF | 1.74 | |||||
| Price-to-Net-Current-Asset-Value | 0.42 | |||||
| Price-to-Net-Cash | 0.46 | |||||
| Earnings Yield (Greenblatt) % | 107.53 | |||||
| FCF Yield % | -105.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SPRB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Spruce Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 10.089 | ||
| EPS (TTM) ($) | -1.25 | ||
| Beta | 2.68 | ||
| Volatility % | 162.63 | ||
| 14-Day RSI | 37.72 | ||
| 14-Day ATR ($) | 0.070079 | ||
| 20-Day SMA ($) | 0.750945 | ||
| 12-1 Month Momentum % | -67.63 | ||
| 52-Week Range ($) | 0.6711 - 5.95 | ||
| Shares Outstanding (Mil) | 41.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Spruce Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Spruce Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Spruce Biosciences Inc Frequently Asked Questions
What is Spruce Biosciences Inc(SPRB)'s stock price today?
The current price of SPRB is $0.77. The 52 week high of SPRB is $5.95 and 52 week low is $0.67.
When is next earnings date of Spruce Biosciences Inc(SPRB)?
The next earnings date of Spruce Biosciences Inc(SPRB) is 2024-08-14 Est..
Does Spruce Biosciences Inc(SPRB) pay dividends? If so, how much?
Spruce Biosciences Inc(SPRB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers